Skip to main content
×
Home
    • Aa
    • Aa

Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks

  • Barbara S. van der Meij (a1), Coline P. Schoonbeek (a1), Egbert F. Smit (a2), Maurizio Muscaritoli (a3), Paul A. M. van Leeuwen (a4) and Jacqueline A. E. Langius (a1)...
Abstract

Despite the development of consensus-based frameworks to define cancer cachexia, the validity and usefulness of these frameworks are relatively unknown. The aim of the present study was to study the presence of pre-cachexia and cachexia in patients with stage III non-small-cell lung carcinoma (NSCLC) by using a cancer-specific framework and a general framework for cachexia, and to explore the prognostic value of pre-cachexia and cachexia. In forty patients at diagnosis of stage III NSCLC, weight loss, fat-free mass, handgrip strength, anorexia and serum biochemistry, assessed before the first chemotherapy, were used to define ‘cancer cachexia’ or ‘cachexia’. The cancer-specific framework also classified for pre-cachexia and refractory cachexia. Additionally, quality of life was assessed by the European Organisation for Research and Treatment of Cancer – Quality of Life Questionnaire C30. Groups were compared using independent t tests, ANOVA, Kaplan–Meier and Cox survival analyses. Based on the cancer-specific framework, pre-cachexia was present in nine patients (23 %) and cancer cachexia was present in seven patients (18 %). Cancer cachexia was associated with a reduced quality of life (P= 0·03) and shorter survival (hazard ratio (HR) = 2·9; P= 0·04). When using the general framework, cachexia was present in eleven patients (28 %), and was associated with a reduced quality of life (P= 0·08) and shorter survival (HR = 4·4; P= 0·001). In conclusion, pre-cachexia and cachexia are prevalent in this small population of patients at diagnosis of stage III NSCLC. For both frameworks, cachexia appears to be associated with a reduced quality of life and shorter survival. Further studies are warranted to more extensively explore the validity and prognostic value of these new frameworks in cancer patients.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: B. S. van der Meij, fax +31 20 444 4143, email b.vandermeij@vumc.nl
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 M Muscaritoli , SD Anker , J Argiles , et al. (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29, 154159.

2 E Van Cutsem & J Arends (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9, S51S63.

3 MP Davis & D Dickerson (2000) Cachexia and anorexia: cancer's covert killer. Support Care Cancer 8, 180187.

4 K Fearon , F Strasser , SD Anker , et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489495.

5 WJ Evans , JE Morley , J Argiles , et al. (2008) Cachexia: a new definition. Clin Nutr 27, 793799.

6 F Bozzetti & L Mariani (2009) Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr 33, 361367.

7 KM Fox , JM Brooks , SR Gandra , et al. (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009, 693458.

8 JM Argiles , FJ Lopez-Soriano , M Toledo , et al. (2011) The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachex Sarcopenia Muscle 2, 8793.

9 PJ Ross , S Ashley , A Norton , et al. (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90, 19051911.

10 WD Dewys , C Begg , PT Lavin , et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491497.

11 A Laviano & MM Meguid (1996) Nutritional issues in cancer management. Nutrition 12, 358371.

12 JP Simons , AM Schols , WA Buurman , et al. (1999) Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) 97, 215223.

14 L Ovesen , J Hannibal & EL Mortensen (1993) The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer 19, 159167.

16 F Martin , F Santolaria , N Batista , et al. (1999) Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11, 8086.

17 BS Meij van der , JAE Langius , EF Smit , et al. (2010) Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140, 17741780.

20 UG Kyle , L Genton , L Karsegard , et al. (2001) Single prediction equation for bioelectrical impedance analysis in adults aged 20–94 years. Nutrition 17, 248253.

21 D Gupta , CA Lammersfeld , PG Vashi , et al. (2009) Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer 9, 37.

22 JB Weir (1949) New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109, 19.

24 AW Moses , C Slater , T Preston , et al. (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90, 9961002.

28 F Dati , AM Johnson & JT Whicher (2001) The existing interim consensus reference ranges and the future approach. Clin Chem Lab Med 39, 11341136.

29 RW Bohannon , A Peolsson , N Massy-Westropp , et al. (2006) Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy 92, 1115.

32 SM Slootmaker , MJ Chinapaw , AJ Schuit , et al. (2005) Promoting physical activity using an activity monitor and a tailored web-based advice: design of a randomized controlled trial [ISRCTN93896459]. BMC Public Health 5, 134.

33 SM Slootmaker , MJ Chinapaw , AJ Schuit , et al. (2009) Concurrent validity of the PAM accelerometer relative to the MTI Actigraph using oxygen consumption as a reference. Scand J Med Sci Sports 19, 3643.

36 HJ Andreyev , AR Norman , J Oates , et al. (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503509.

37 DC McMillan , JE Crozier , K Canna , et al. (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22, 881886.

38 X Jiang , N Hiki , S Nunobe , et al. (2012) Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107, 275279.

40 WJ Aronson , N Kobayashi , RJ Barnard , et al. (2011) Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res (Phila) 4, 20622071.

42 CM Op den Kamp , RC Langen , R Minnaard , et al. (2012) Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system. Lung Cancer 76, 112117.

44 AJ Staal-van den Brekel , AM Schols , MA Dentener , et al. (1997) The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 76, 16301635.

45 Z Giannousi , I Gioulbasanis , AG Pallis , et al. (2012) Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis. Support Care Cancer 20, 18231829.

46 I Gioulbasanis , P Georgoulias , PJ Vlachostergios , et al. (2011) Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis. Lung Cancer 74, 516520.

47 EJ Coups , BJ Park , MB Feinstein , et al. (2009) Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiol Biomarkers Prev 18, 664672.

48 E Gibney , M Elia , SA Jebb , et al. (1997) Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46, 14121417.

49 MJ Tisdale (2008) Catabolic mediators of cancer cachexia. Curr Opin Support Palliat Care 2, 256261.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
PDF
Supplementary Materials

van der Meij supplementary material
van der Meij supplementary material

 PDF (28 KB)
28 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 5
Total number of PDF views: 122 *
Loading metrics...

Abstract views

Total abstract views: 182 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 27th May 2017. This data will be updated every 24 hours.